Oragenics Inc. reported on December 11, 2025, that it has increased CEO Janet Huffman's annual salary by 5% to $341,250 and awarded her a bonus of $110,500, along with stock options to purchase 250,000 shares at $0.93 each, effective January 1, 2026.